We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Breakthrough Mass Spectrometry Design Could Enable Ultra-Low Abundance Detection

By LabMedica International staff writers
Posted on 31 Mar 2026

Mass spectrometry is central to identifying and quantifying molecules in complex biological samples, but conventional instruments typically analyze ions sequentially, which can limit detection of rare species. More...

Researchers now describe a prototype that parallelizes ion handling to improve sensitivity for low-abundance targets in challenging matrices. The findings show enhanced dynamic range and signal-to-noise, potentially enabling detection of molecules that were previously undetectable with standard ion traps.

Most current systems examine one or a few ion populations at a time, a limitation that can slow analyses, raise costs, and obscure scarce but informative molecules in single-cell proteomics and metabolomics. Because proteins and metabolites cannot be amplified like nucleic acids, faint signals are easily overwhelmed by background. Improving sensitivity and throughput is therefore a recurring bottleneck for comprehensive molecular readouts.

Investigators at Rockefeller University (New York, NY, USA) developed a prototype called MultiQ‑IT that cools, traps, filters, and redirects more than a billion ions simultaneously. Built to replace the core ion‑trapping stage, the cube‑shaped device is lined with hundreds of electrically controlled openings. Ions are slowed by collisions with residual gas, move stochastically within the chamber, and can be held or routed so that many ion populations are manipulated at once rather than one by one.

The team scaled the design from six openings to more than 1,000 and showed that a single incoming ion stream can be split into multiple parallel streams for simultaneous analysis. In a 486‑port configuration, MultiQ‑IT stored up to ten billion charges—about a thousand times the capacity of conventional ion traps. Applying a small voltage barrier across the exits allowed singly charged background ions to escape while retaining multiply charged, information‑rich ions, improving signal‑to‑noise by as much as 100‑fold and revealing previously undetectable proteins.

In a 1,134‑port design, just 39 open ports achieved half‑maximum depletion efficiency, echoing parallel transport seen in biological pores. The increased sensitivity could, for example, improve detection of low‑abundance crosslinked peptides used to map large protein complexes. The findings outline a physical blueprint for faster, more sensitive instruments and point toward routine, high‑throughput single‑cell proteomics. The work appears in Science Advances.

“It was the ability to run so many chemical reactions in parallel, which took genome sequencing from a billion-dollar effort to something that costs around $100. The same thing happened in computing with GPUs. And that’s what we’re trying to do with mass spectrometry,” said Brian T. Chait, the Camille and Henry Dreyfus Professor at The Rockefeller University.

Related Links
The Rockefeller University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Industry

view channel
Image: AlzoSure Predict is designed to help clinicians assess the likelihood of Alzheimer’s disease progression in patients with mild cognitive impairment. (Photo courtesy of Diadem)

Alzheimer’s Progression Blood Test Gains U.S. Patent Ahead of Planned Launch

Alzheimer’s disease is the most common cause of dementia, accounting for an estimated 60–70% of cases worldwide. Its progressive effects on memory, thinking, behavior, and daily functioning underscore... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.